Written by
If you’ve taken high-dose vitamin C supplements and felt underwhelmed, it’s not just in your head.
The body tightly regulates vitamin C at every step, from absorption to excretion. Beyond a relatively modest dose, more vitamin C doesn’t mean more inside the systems that depend on it. Which is why most supplements hit a plateau before they can deliver meaningful results.
The fix isn’t adding more vitamin C. It’s smarter delivery.
In this article, we’ll break down why most vitamin C supplements hit a biological ceiling, how optimized forms — including liposomal vitamin C — change that equation, and what actually determines whether vitamin C reaches your cells.
Why Don't Most Vitamin C Supplements Work?
Most vitamin C supplements don’t work as expected because the body can only absorb a limited amount at once, and excess vitamin C is quickly excreted.
If your goal is just avoiding deficiency, most vitamin C supplements do what they’re supposed to do.
But that’s a very low bar.
If you’re aiming for immune resilience, connective tissue support, or sustained antioxidant capacity, a basic supplement may not cut it.
Vitamin C absorption is regulated. Past a certain dose, absorption efficiency drops sharply and the kidneys begin clearing the excess [1].
That matters because circulating vitamin C is requisite fuel for the systems that burn through ascorbic acid fastest, including the immune system, the adrenal system, and the brain — as well as the collagen-rich connective tissues that depend on vitamin C for structural integrity [2–4].
These tissues actively concentrate vitamin C and turn it over relentlessly. When plasma levels stay higher for longer, their functional ceiling rises with it.*
What Is Vitamin C Bioavailability?
Vitamin C bioavailability refers to how much of a dose actually enters circulation and remains available for use. At higher doses, that fraction drops sharply.
The Absorption Cliff
Much of our understanding of vitamin C kinetics comes from a series of tightly controlled inpatient studies in the 1990s [5].
Participants were depleted of vitamin C, then given precise doses while researchers measured both plasma levels (how much vitamin C was in circulation) and absorption efficiency (how much of a dose actually entered the bloodstream).
Plasma vitamin C concentrations didn't rise steadily with dose. Instead, they followed a steep S-shaped pattern.
Between 30 and 100 mg per day, small increases in intake produced large jumps in circulating levels. But above 200mg, the curve started to flatten. The concentrations reached at 200 mg per day were similar to those seen at 400 mg, 1000 mg, and even 2500 mg. Doubling or tripling the dose did not meaningfully increase how much the body holds.
At the same time, absorption efficiency falls as intake rises.
Up to ~200 mg, uptake is nearly complete. At 500 mg, uptake drops to ~73%. At 1250 mg, it falls to ~49% — meaning more than half the dose never enters circulation at all. At that point, more vitamin C is lost than absorbed.
The system closes in from both sides. Less of each dose makes it past the gut, and what does get in doesn’t raise circulating levels much further.
The Transporter Problem
Vitamin C can't passively diffuse through the body. It depends on transporter proteins, and those transporters have limits.
In the gut, a transporter called SVCT1 sits on the surface of intestinal cells and actively pulls vitamin C into circulation. It works efficiently at lower doses, but it has a fixed capacity. Once that capacity is exceeded, much of the excess will be left behind [6].
It's kind of like a turnstile. At low traffic, everyone gets through. But as the crowd builds, a line forms — and no matter how many more people show up, the rate of entry doesn’t increase.
So beyond a certain point, increasing the dose doesn’t meaningfully increase circulating vitamin C.
Ascorbic Acid vs Vitamin C: Are They the Same?
Ascorbic acid is the core form of vitamin C, but “vitamin C” on a label can refer to a range of related forms and formulations.
When you see “vitamin C” on a supplement label, it may include:
Ascorbic acid itself (the base molecule)
Mineral ascorbates (e.g., calcium, magnesium, or zinc ascorbate)
Modified or structured forms (e.g., lipid-associated or encapsulated versions)
Formulations that pair vitamin C with other compounds (like bioflavonoids or plant extracts)
All of these deliver vitamin C, but they don’t end up in the body the same way.
What Are the Different Forms of Vitamin C?
Vitamin C supplements come in several forms, including pure ascorbic acid, mineral ascorbates (such as calcium ascorbate and Ester-C), and delivery systems like liposomal vitamin C.
Pure Ascorbic Acid
When you see “vitamin C” on a label, this is usually what you’re getting. At lower doses, it’s efficiently absorbed and generally does its job. But problems start to emerge as the dose goes up.
The first is obvious. Ascorbic acid is, well, an acid. In solution, it sits around a pH of 2.4–2.5. At higher doses, especially on an empty stomach, that can translate to serious irritation for some people [7].
Then there is a second, subtler issue.
Ascorbic acid is chemically unstable under certain conditions, and the harsh environment of the stomach is one of them. Before it even reaches the small intestine — where absorption actually occurs — some of it can be oxidized to dehydroascorbic acid (DHA), an unstable intermediate prone to degradation [8].
This dilemma has driven the development of modified forms designed to modulate the fragility and acidity of ascorbic acid. Mineral ascorbates are the first step in that evolution.
Mineral Ascorbates
The simplest way to take the edge off pure ascorbic acid is to buffer it. Mineral ascorbates do exactly that. These are forms of vitamin C where ascorbic acid is combined with minerals, forming salts like calcium ascorbate or magnesium ascorbate.
By replacing the hydrogen ion responsible for ascorbic acid’s acidity with a mineral ion, its chemical character is changed. Your stomach gets the ascorbate — the active part — without the acid load of plain ascorbic acid [9].
It’s the same basic principle as an antacid, except the neutralization happens before you swallow it.
The result is a form of vitamin C that’s gentler on the stomach and easier to tolerate at higher doses. That makes higher-dose use more sustainable.
Mineral ascorbates solve the acidity problem. But they don’t solve the absorption ceiling.
That is where more advanced delivery systems come into play.
Liposomal Delivery Systems
No matter how well-tolerated it is, vitamin C still has to cross the intestinal wall. Buffering the pH doesn’t really change that constraint [10].
Here's the problem: the surface of intestinal cells is made of lipid membranes, which act as a barrier to water-soluble molecules like vitamin C. Ascorbic acid can't get through that barrier by itself; it has to be carried by transporters with a fixed throughput limit.
Liposomal delivery bypasses that route.
Liposomes are spherical vesicles made of phospholipid bilayers, built from the same type of material as the cell membrane.
When the liposome contacts the intestinal cell surface, it is recognized as structurally compatible and engulfed whole, a process known as endocytosis. This carries the vitamin C payload inside the cell without relying on SVCT1 transporters [11].
Once inside the cell, the lipid-based carrier joins the same transport pathways used for dietary fats, allowing vitamin C to move through the lymphatic system rather than relying solely on SVCT1-mediated uptake. The lymphatic system moves lipid-packaged cargo in bulk, so it doesn't have the same transporter limits of SVCT1 [12].
Why Liposomal Vitamin C is Better
Liposomal vitamin C is better because it bypasses transport bottlenecks, resulting in higher levels of vitamin C in the bloodstream and greater uptake in high-demand tissue like immune cells.
Higher Circulating Vitamin C Levels
Standard vitamin C absorption is capped by intestinal transporter saturation and subsequent kidney clearance. Liposomal vitamin C is designed to work around that constraint. But does it truly deliver?
In a crossover trial, researchers had 24 people visit the lab on two separate occasions [13]. During these sessions, they were given:
1,000 mg of standard vitamin C
1,000 mg of liposomal vitamin C
When participants took liposomal vitamin C, peak plasma levels were about 2.4× higher, compared to the standard vitamin C. This translated to nearly double the total exposure to vitamin C.
But higher blood levels only matter if tissues can actually use that vitamin C.
Greater Uptake into Cells
Vitamin C doesn't do its work in the bloodstream. It does its work inside cells, where it acts as a cofactor for the enzymes that build collagen and supports immune defense. Plasma is the delivery vehicle, but the destination is the tissue [14].
So the question is whether the higher circulating levels elicited by liposomal vitamin C translate to more vitamin C inside cells.
A randomized, double-blind crossover trial tested this directly [15]. On three separate visits, 27 subjects received:
500 mg of standard vitamin C
500 mg of a liposomal formulation
Placebo
Researchers measured vitamin C in plasma and in leukocytes (immune cells) for 24 hours after supplementation.
Liposomal vitamin C produced about 20% higher peak vitamin C levels inside immune cells, along with greater total cellular exposure across the day.
Leukocytes are among the most vitamin-C-dependent cells in the body. They actively concentrate the vitamin to levels far above what circulates in plasma, and they rely on it to mount an effective immune response [2].
That dependence shows up in function.
In a separate study, increasing levels of vitamin C stored inside immune cells made the immune cells measurably better at doing their job [16].
The leukocytes became 20% more efficient at chemotaxis, or the ability to navigate toward infection signals. At the same time, their oxidative burst output — the release of reactive compounds used to attack pathogens — rose by ~23%.
More vitamin C in circulation means more inside the body's most metabolically demanding tissues, and improvements in how systems tissues perform.
What Makes Qualia Vitamin C+ Different?
Vitamin C’s impact is limited less by the dose and more by the delivery system.
Qualia Vitamin C+ is built around that principle: combining multiple forms to address the bottlenecks that constrain standard vitamin C: absorption, cellular uptake, retention, and tolerability.*
The backbone is Liposomal PureWay‐C®. In a clinical trial, PureWay‐C® achieved the highest serum levels at every time point, compared to three other forms of vitamin C [17].*
And that increase in circulating levels translates into greater tissue uptake. In lab studies of human immune cells, PureWay-C® entered cells more than twice as fast as standard ascorbic acid and raised intracellular vitamin C levels by ~65% [18].*
It’s paired with Nutra-C®, a buffered form of vitamin C composed of calcium and magnesium ascorbates. By neutralizing the acidity of ascorbic acid, it improves tolerability and helps preserve the vitamin in its active form during transit.
In a pharmacokinetic study, Nutra-C® produced higher serum vitamin C levels across the full measurement window, with ~28% greater total exposure (AUC) than standard ascorbic acid from the same dose [19].*
From there, Qualia Vitamin C+ adds three synergistic layers that shape how vitamin C behaves inside the body:
1. Bioflavonoids
Vitamin C is a potent antioxidant, but that same reactivity makes it vulnerable — meaning it can degrade before your body absorbs it [20–22].
Bioflavonoids act as a stabilizing partner, limiting oxidative breakdown so more vitamin C remains intact through digestion. In human research, vitamin C delivered alongside bioflavonoids showed ~35% greater absorption than ascorbic acid alone [23].*
2. Ferulic acid
Vitamin C is spent as soon as it neutralizes a free radical. Ferulic acid stabilizes the intermediate forms of vitamin C and supports its return to an active state, extending its usefulness [24]. Together, they reinforce antioxidant defenses at the cell membrane.*
3) A whole-fruit polyphenol matrix
Camu camu, acerola, amla, and rose hips deliver vitamin C inside a dense polyphenol matrix — the same kind of biochemical environment found in whole fruit. In clinical research, acerola-derived vitamin C was excreted less than pure synthetic ascorbic acid, indicating better retention and a slower drop-off in circulating levels [25].*
When you lift the bottlenecks that limit vitamin C, you raise its functional ceiling. Qualia Vitamin C+ is built to do exactly that, giving your cells more vitamin C, for longer, in the form they can actually use.*
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
[1] S.J. Padayatty, H. Sun, Y. Wang, H.D. Riordan, S.M. Hewitt, A. Katz, R.A. Wesley, M. Levine, Ann. Intern. Med. 140 (2004) 533–537.
[2] A.C. Carr, S. Maggini, Nutrients 9 (2017) 1211.
[3] J.M. Pullar, A.C. Carr, M.C.M. Vissers, Nutrients 9 (2017) 866.
[4] D. Hornig, World Rev. Nutr. Diet. 23 (1975) 225–258.
[5] M. Levine, C. Conry-Cantilena, Y. Wang, R.W. Welch, P.W. Washko, K.R. Dhariwal, J.B. Park, A. Lazarev, J.F. Graumlich, J. King, L.R. Cantilena, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3704–3709.
[6] J. Lykkesfeldt, P. Tveden-Nyborg, Nutrients 11 (2019) 2412.
[7] S.J. Padayatty, M. Levine, Oral Dis. 22 (2016) 463–493.
[8] P.C. Calder, R.B. Kreider, D.L. McKay, Nutrients 17 (2025) 279.
[9] J.K. Lee, S.H. Jung, S.E. Lee, J.H. Han, E. Jo, H.S. Park, K.S. Heo, D. Kim, J.S. Park, C.S. Myung, Korean J. Physiol. Pharmacol. 22 (2018) 35–42.
[10] T. Dhotre, S. Thanawala, R. Shah, Pharmaceutics 17 (2025) 1458.
[11] A.C. Carr, Basic Clin. Pharmacol. Toxicol. 137 (2025) e70067.
[12] H. Ahn, J.H. Park, Biomater. Res. 20 (2016) 36.
[13] S. Gopi, P. Balakrishnan, J. Liposome Res. 31 (2021) 356–364.
[14] J. Lykkesfeldt, A.C. Carr, P. Tveden-Nyborg, Pharmacol. Rev. 77 (2025) 100043.
[15] M. Purpura, R. Jäger, A. Godavarthi, D. Bhaskarachar, G.M. Tinsley, Eur. J. Nutr. 63 (2024) 3037–3046.
[16] S.M. Bozonet, A.C. Carr, J.M. Pullar, M.C. Vissers, Nutrients 7 (2015) 2574–2588.
[17] D. Pancorbo, C. Vazquez, M.A. Fletcher, Med. Sci. Monit. 14 (2008) CR547–CR551.
[18] B.S. Weeks, P.P. Perez, Med. Sci. Monit. 13 (2007) BR205–BR210.
[19] K.-M. Choi, M.H. Kim, T.W. Hwang, J.-D. Kim, K.D. Park, M.-Y. Kim, Y.-R. Jung, H.-S. Shin, Anal. Sci. Technol. 29 (2016) 162–169.
[20] B.Y. Beker, I. Sönmezoğlu, F. Imer, R. Apak, Int. J. Food Sci. Nutr. 62 (2011) 504–512.
[21] C.A. Clemetson, L. Andersen, Ann. N. Y. Acad. Sci. 136 (1966) 341–376.
[22] A.C. Carr, M.C. Vissers, Nutrients 5 (2013) 4284–4304.
[23] J.A. Vinson, P. Bose, Am. J. Clin. Nutr. 48 (1988) 601–604.
[24] S. Trombino, S. Serini, F. Di Nicuolo, L. Celleno, S. Andò, N. Picci, G. Calviello, P. Palozza, J. Agric. Food Chem. 52 (2004) 2411–2420.
[25] E. Uchida, Y. Kondo, A. Amano, S. Aizawa, T. Hanamura, H. Aoki, K. Nagamine, T. Koizumi, N. Maruyama, A. Ishigami, Biol. Pharm. Bull. 34 (2011) 1744–1747.
